Media reports suggest that Cipla’s Indore facility is being audited by USFDA. In January 2018, Cipla’s Goa unit was audited by USFDA, flagging routine procedural observations. Cipla, post the form 483 observations stated that it has received product approvals from Goa despite the observations, easing investor concerns.Indore is a formulations manufacturing facility. The Indore SEZ facility had received nine USFDA observations in 2015 and was cleared in 2016. As per one of the earlier management comments, Indore is not a very signficant plant at the moment as it is a newer plant.
CapitalStars Award Winning , SEBI registered , ISO certified investment advisory company. We provide intraday & positional services in Equity , derivative ,commodity & currency. Our research is highly skilled & experienced .
Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.CapitalStars Investment Adviser: SEBI Registration Number: INA000001647
MCX CALL: BUY GOLD AT 31300 TARGETS 31340 / 31390 / 31450 STOPLOSS 31240
ReplyDeleteGET DAILY: MCX Live RATE
QUICK FREE TRIAL
ReplyDeleteMCX CALL: BUY NICKEL ABOVE 1032.00 TARGETS 1038.00 / 1048.00 / 1058.00 STOPLOSS 1023.00
MCX UPDATE: FIRE FIRE FIRE...NICKEL BUY CALL HAS ACHIEVED FINAL TARGET 1058 BOOK FULL PROFIT NEW HIGH 1062
MCX COMMODITY TIPS